1838 ET - Ord Minnett takes a less rosy view of life sciences devices maker Trajan's earnings as tariffs and geopolitical uncertainty create headwinds. The bank trims its medium-term net profit forecasts by 3% after updating assumptions to align with Trajan's FY 2026 guidance. These assumptions include weaker equipment sales and a repositioning of Trajan's supply chain. Still, Ord Minnett retains a buy call on the stock. "Notwithstanding near-term headwinds, Trajan remains a founder-led business with a material growth opportunity and an undemanding valuation" of 15x FY 2027 estimated price-to-earnings, analyst Tom Godfrey says. Ord Minnett's price target falls 14% to A$1.25/share. Trajan ended Tuesday at A$0.795. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
September 09, 2025 18:38 ET (22:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.